Relief from SIBO not only alleviates the GI discomfort, but it also helps in the amelioration of the motor fluctuations experienced by PD patients (Gabrielli et al., 2011
Breast cancer studies have provided additional insights into SFNs clinical activity
Lower Calorie Intake May Affect Skin Quality GLP-1 medications often reduce appetite so significantly that overall nutrition patterns change
This dual action not only aids in glycemic control but also addresses weight management, a critical factor for many individuals with type 2 diabetes
Furthermore, ICV injection of Ex-4 into the 4th ventricle of rats causes a suppression of food intake (Hayes et al., 2011)
Tirzepatide is the established option with FDA approval, extensive clinical trial data, and growing real-world evidence supporting its efficacy in both type 2 diabetes and obesity